Getting your player ready...
The company’s orthopedic-device unit is recalling hip-replacement parts implanted in about 93,000 people worldwide because of a high rate of repeat surgeries needed, adding a new quality problem for the health-products titan.
A Johnson & Johnson spokesman said Thursday the company is still evaluating the financial impact of the recall, which does not require patients to have implants removed. Instead, the company’s De Puy Orthopaedics subsidiary advised patients with its ASR hip parts to visit their surgeons for evaluation of device performance. It also recommended yearly monitoring and said it plans to cover “reasonable and customary costs” linked to the recall.
Denver Post wire services
